|
1
|
World Health Organization: Chronic
obstructive pulmonary disease (COPD) Fact sheet March 2015. WHO.
http://www.who.int/mediacentre/factsheets/fs315/en/.
2015.
|
|
2
|
Milara J, Peiró T, Serrano A, Guijarro R,
Zaragozá C, Tenor H and Cortijo J: Roflumilast N-oxide inhibits
bronchial epithelial to mesenchymal transition induced by cigarette
smoke in smokers with COPD. Pulm Pharmacol Ther. 28:138–148.
2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chung KF and Marwick JA: Molecular
mechanisms of oxidative stress in airways and lungs with reference
to asthma and chronic obstructive pulmonary disease. Ann NY Acad
Sci. 1203:85–91. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
MacNee W: Pulmonary and systemic
oxidant/antioxidant imbalance in chronic obstructive pulmonary
disease. Proc Am Thorac Soc. 2:50–60. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Burgel PR and Martin C: Mucus
hypersecretion in COPD: Should we only rely on symptoms? Eur Respir
Rev. 19:94–96. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cole SP: Targeting multidrug resistance
protein 1 (MRP1, ABCC1): Past, present, and future. Annu Rev
Pharmacol Toxicol. 54:95–117. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cole SP, Bhardwaj G, Gerlach JH, Mackie
JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and
Deeley RG: Overexpression of a transporter gene in a
multidrug-resistant human lung cancer cell line. Science.
258:1650–1654. 1992.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Budulac SE, Postma DS, Hiemstra PS,
Lapperre TS, Kunz LI, Vonk JM, Marike Boezen H and Timens W:
Glucold Study Group. Multidrug resistance-associated protein 1 and
lung function decline with or without long-term corticosteroids
treatment in COPD. Eur J Pharmacol. 696:136–142. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang DL, Zhang X and Tao XH: Effects of
huatan jianqi capsule on the levels of multidrug
resistance-associated protein 1 in the bronchial epithelial cells
of model rats with chronic obstructive pulmonary disease. Zhongguo
Zhong Xi Yi Jie He Za Zhi. 32:955–959. 2012.PubMed/NCBI(In Chinese).
|
|
10
|
Wang GZ, Peng B, Han MX, Li ZG, Han NL and
Zhang NZ: The effect of huatan jiangqi capsule on pulmonary
function and arterial blood gas in patients with COPD. Zhongguo
Zhong Yi Ji Zheng. 15:1311–1312. 2006.
|
|
11
|
Kushad MM, Brown AF, Kurilich AC, Juvik
JA, Klein BP, Wallig MA and Jeffery EH: Variation of glucosinolates
in vegetable crops of Brassica oleracea. J Agric Food Chem.
47:1541–1548. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Giacoppo S, Galuppo M, Montaut S, Iori R,
Rollin P, Bramanti P and Mazzon E: An overview on neuroprotective
effects of isothiocyanates for the treatment of neurodegenerative
diseases. Fitoterapia. 106:12–21. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu X, Zhou QH and Xu K: Are
isothiocyanates potential anti-cancer drugs? Acta Pharmacol Sin.
30:501–512. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hu K and Morris ME: Effects of benzyl-,
phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein-
and MRP1-mediated transport. J Pharm Sci. 93:1901–1911.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang DL, Wang CY, Cao Y, Zhang X, Tao XH,
Yang LL, Chen JP, Wang SS and Li ZG: Allyl isothiocyanate increases
MRP1 function and expression in a human bronchial epithelial cell
line. Oxid Med Cell Longev. 2014(547379)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang SJ, Wang SS, Wang CY, Chen YJ, Li J,
Wang XQ, Wang DL, Li ZG, Peng ZL and Fan L: Upregulation of
multidrug resistance-associated protein 1 by allyl isothiocyanate
in human bronchial epithelial cell: Involvement of c-Jun N-terminal
kinase signaling pathway. Oxid Med Cell Longev.
2015(903782)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Boutten A, Goven D, Artaud-Macari E,
Boczkowski J and Bonay M: NRF2 targeting: A promising therapeutic
strategy in chronic obstructive pulmonary disease. Trends Mol Med.
17:363–371. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jeong WS, Jun M and Kong AN: Nrf2: A
potential molecular target for cancer chemoprevention by natural
compounds. Antioxid Redox Signal. 8:99–106. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kong AN, Owuor E, Yu R, Hebbar V, Chen C,
Hu R and Mandlekar S: Induction of xenobiotic enzymes by the MAP
kinase pathway and the antioxidant or electrophile response element
(ARE/EpRE). Drug Metab Rev. 33:255–271. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shaulian E and Karin M: AP-1 in cell
proliferation and survival. Oncogene. 20:2390–2400. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Fisk M, Gajendragadkar PR, Mäki-Petäjä KM,
Wilkinson IB and Cheriyan J: Therapeutic potential of p38 MAP
kinase inhibition in the management of cardiovascular disease. Am J
Cardiovasc Drugs. 14:155–165. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee H, Park JR, Kim EJ, Kim WJ, Hong SH,
Park SM and Yang SR: Cigarette smoke-mediated oxidative stress
induces apoptosis via the MAPKs/STAT1 pathway in mouse lung
fibroblasts. Toxicol Lett. 240:140–148. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shang J and Zhao J, Wu X, Xu Y, Xie J and
Zhao J: Interleukin-33 promotes inflammatory cytokine production in
chronic airway inflammation. Biochem Cell Biol. 93:359–366.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saetta M, Turato G, Baraldo S, Zanin A,
Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A and Fabbri
LM: Goblet cell hyperplasia and epithelial inflammation in
peripheral airways of smokers with both symptoms of chronic
bronchitis and chronic airflow limitation. Am J Respir Crit Care
Med. 161:1016–1021. 2000.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Global Initiative for Chronic Obstructive
Lung Disease (GOLD): Global Strategy for Diagnosis Management and
Prevention of COPD EB/OL. http://www.goldcopd.org/. 2013.
|
|
27
|
Muro S: Cigarette smoking is the most
important causal factor for developing chronic obstructive
pulmonary disease (COPD). Nihon Rinsho. 69:1735–1740.
2011.PubMed/NCBI(In Japanese).
|
|
28
|
Caramori G, Kirkham P, Barczyk A, Stefano
AD and Adcock I: Molecular pathogenesis of cigarette
smoking-induced stable COPD. Ann N Y Acad Sci Mar. 1340:55–64.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hwang JW, Chung S, Sundar IK, Yao H,
Arunachalam G, McBurney MW and Rahman I: Cigarette smoke-induced
autophagy is regulated by SIRT1-PARP-1-dependent mechanism:
Implication in pathogenesis of COPD. Arch Biochem. 500:203–209.
2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mercado N, Ito K and Barnes PJ:
Accelerated ageing of the lung in COPD: New concepts. Thorax.
70:482–489. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Malhotra D, Thimmulappa R, Vij N,
Navas-Acien A, Sussan T, Merali S, Zhang L, Kelsen SG, Myers A,
Wise R, et al: Heightened endoplasmic reticulum stress in the lungs
of patients with chronic obstructive pulmonary disease: The role of
Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med.
180:1196–1207. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Long Y, Li Q, Wang Y and Cui Z: MRP
proteins as potential mediators of heavy metal resistance in
zebrafish cells. Comp Biochem Physiol C Toxicol Pharmacol.
153:310–317. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Guan J, Chen XP, Zhu H, Luo SF, Cao B and
Ding L: Involvement of extracellular signal-regulated
kinase/mitogen-activated protein kinase pathway in multidrug
resistance induced by HBx in hepatoma cell line. World J
Gastroenterol. 10:3522–3527. 2004.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hayashi K, Pu H, Andras IE, Eum SY,
Yamauchi A, Hennig B and Toborek M: HIV-TAT protein upregulates
expression of multidrug resistance protein 1 in the blood-brain
barrier. J Cereb Blood Flow Metab. 26:1052–1065. 2006.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ronaldson PT, Ashraf T and Bendayan R:
Regulation of multidrug resistance protein 1 by tumor necrosis
factor alpha in cultured glial cells: Involvement of nuclear
factor-kappaB and c-Jun N-terminal kinase signaling pathways. Mol
Pharmacol. 77:644–659. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kwon YS, Chun SY, Nam KS and Kim S:
Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to
doxorubicin by inhibiting the expression of multidrug
resistance-associated protein-1. Oncol Rep. 34:884–890.
2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang DL, Zhang X, Tao XH, Cao Y and Peng
B: Expression of multidrug resistance-associated protein 1 in
bronchial epithelium of model srat with chronic obstructive
pulmonary disease and the reversal effects of Huatanjiangqi Capsule
on it. Chin J Clin Pharm Therap. 17:621–625. 2012.
|
|
38
|
Shen HJ, Sun YH, Zhang SJ, Jiang JX, Dong
XW, Jia YL, Shen J, Guan Y, Zhang LH, Li FF, et al: Cigarette
smoke-induced alveolar epithelial-mesenchymal transition is
mediated by Rac1 activation. Biochim Biophys Acta. 1840:1838–1849.
2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tharakan A, Halderman AA, Lane AP, Biswal
S and Ramanathan M Jr: Reversal of cigarette smoke extract-induced
sinonasal epithelial cell barrier dysfunction through Nrf2
activation. Int Forum Allergy Rhino. 6:1145–1150. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yu G, Zeng X and Wang H, Hou Q, Tan C, Xu
Q and Wang H: 14,15-epoxyeicosatrienoic Acid suppresses cigarette
smoke extract-induced apoptosis in lung epithelial cells by
inhibiting endoplasmic reticulum stress. Cell Physiol Biochem.
36:474–486. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Huang C, Wang JJ, Ma JH, Jin C, Yu Q and
Zhang SX: Activation of the UPR protects against cigarette
smoke-induced RPE apoptosis through up-regulation of Nrf2. J Biol
Chem. 290:5367–5380. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Truong VL, Bak MJ, Jun M, Kong AN, Ho CT
and Jeong WS: Antioxidant defense and hepatoprotection by
procyanidins from almond (Prunus amygdalus) skins. J Agric
Food Chem. 62:8668–8678. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lee DS, Li B, Kim KS, Jeong GS, Kim EC and
Kim YC: Butein protects human dental pulp cells from hydrogen
peroxide-induced oxidative toxicity via Nrf2 pathway-dependent heme
oxygenase-1 expressions. Toxicol In Vitro. 27:874–881.
2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ji LL, Sheng YC, Zheng ZY, Shi L and Wang
ZT: The involvement of p62-Keap1-Nrf2 antioxidative signaling
pathway and JNK in the protection of natural flavonoid quercetin
against hepatotoxicity. Free Radic Biol Med. 85:12–23.
2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Juge N, Mithen RF and Traka M: Molecular
basis for chemoprevention by sulforaphane: A comprehensive review.
Cell Mol Life Sci. 64:1105–1127. 2007.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Heiss E, Herhaus C, Klimo K, Bartsch H and
Gerhäuser C: Nuclear factor kappa B is a molecular target for
sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem.
276:32008–32015. 2001.PubMed/NCBI View Article : Google Scholar
|
